Paper41367892
Machine Learning-Derived Diverse Regulated Cell Death Patterns for Therapeutic Target Identification in Glaucoma.
Mou Q and 4 others. Int J Gen Med, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Machine Learning-Derived Diverse Regulated Cell Death Patterns for Therapeutic Target Identification in Glaucoma. Papers, record 41367892. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41367892
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Machine Learning-Derived Diverse Regulated Cell Death Patterns for Therapeutic Target Identification in Glaucoma.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References46
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38086421 | A molecular switch for neuroprotective astrocyte reactivity. | Nature | 2024 | https://conductscience.org/library/papers/38086421 | PubMed |
| 2 | 25236395 | Essential versus accessory aspects of cell death: recommendations of the NCCD 2015. | Cell Death Differ | 2015 | https://conductscience.org/library/papers/25236395 | PubMed |
| 3 | 33582161 | Glaucoma and neuroinflammation: An overview. | Surv Ophthalmol | 2021 | https://conductscience.org/library/papers/33582161 | PubMed |
| 4 | 34504660 | From pyroptosis, apoptosis and necroptosis to PANoptosis: A mechanistic compendium of programmed cell death pathways. | Comput Struct Biotechnol J | 2021 | https://conductscience.org/library/papers/34504660 | PubMed |
| 5 | 37742700 | Glaucoma: now and beyond. | Lancet | 2023 | https://conductscience.org/library/papers/37742700 | PubMed |
| 6 | 30948788 | The molecular machinery of regulated cell death. | Cell Res | 2019 | https://conductscience.org/library/papers/30948788 | PubMed |
| 7 | 28743494 | Neural Glycosylphosphatidylinositol-Anchored Proteins in Synaptic Specification. | Trends Cell Biol | 2017 | https://conductscience.org/library/papers/28743494 | PubMed |
| 8 | 28980752 | Intermediate filaments and cellular mechanics. | Cell Biol Int | 2018 | https://conductscience.org/library/papers/28980752 | PubMed |
| 9 | 24825645 | The pathophysiology and treatment of glaucoma: a review. | JAMA | 2014 | https://conductscience.org/library/papers/24825645 | PubMed |
| 10 | 24974815 | Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. | Ophthalmology | 2014 | https://conductscience.org/library/papers/24974815 | PubMed |
| 11 | 35585091 | Novel role of the synaptic scaffold protein Dlgap4 in ventricular surface integrity and neuronal migration during cortical development. | Nat Commun | 2022 | https://conductscience.org/library/papers/35585091 | PubMed |
| 12 | 35637215 | Inhibiting multiple forms of cell death optimizes ganglion cells survival after retinal ischemia reperfusion injury. | Cell Death Dis | 2022 | https://conductscience.org/library/papers/35637215 | PubMed |
| 13 | 39848861 | Unlocking the signaling potential of GPI-anchored proteins through lipolytic cleavage. | Trends Cell Biol | 2025 | https://conductscience.org/library/papers/39848861 | PubMed |
| 14 | 35950752 | Regulated cell death in cancer: from pathogenesis to treatment. | Chin Med J (Engl) | 2023 | https://conductscience.org/library/papers/35950752 | PubMed |
| 15 | 35614865 | Retinal Ganglion Cell Death in Glaucoma: Advances and Caveats. | Curr Eye Res | 2023 | https://conductscience.org/library/papers/35614865 | PubMed |
| 16 | 34897284 | CD82 protects against glaucomatous axonal transport deficits via mTORC1 activation in mice. | Cell Death Dis | 2021 | https://conductscience.org/library/papers/34897284 | PubMed |
| 17 | 37531415 | Gut-licensed β7+ CD4+ T cells contribute to progressive retinal ganglion cell damage in glaucoma. | Sci Transl Med | 2023 | https://conductscience.org/library/papers/37531415 | PubMed |
| 18 | 20457745 | MSEA: a web-based tool to identify biologically meaningful patterns in quantitative metabolomic data. | Nucleic Acids Res | 2010 | https://conductscience.org/library/papers/20457745 | PubMed |
| 19 | 33320171 | T and B Lymphocyte Deficiency in Rag1-/- Mice Reduces Retinal Ganglion Cell Loss in Experimental Glaucoma. | Invest Ophthalmol Vis Sci | 2020 | https://conductscience.org/library/papers/33320171 | PubMed |
| 20 | 9754951 | Plectin in the human central nervous system: predominant expression at pia/glia and endothelia/glia interfaces. | Acta Neuropathol | 1998 | https://conductscience.org/library/papers/9754951 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| DLGAP4 | 22839 | PubTator's text mining | https://conductscience.org/library/genes/22839 | NCBI Gene |
| PLEC | 5339 | PubTator's text mining | https://conductscience.org/library/genes/5339 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41367892
GET https://conductscience.org/api/papers/v1/41367892/references?page=2